A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A23L 1/30 (2006.01) A61K 31/202 (2006.01) A61K 31/557 (2006.01)
Patent
CA 2384502
Cancer in a mammal can be treated or prevented by administering to a mammal in need thereof a cancer inhibiting amount of metabolite(s) of .alpha.-linolenic acid, such as stearidonic acid (18:4 n-3), eicosatetraenoic acid (20:4 n-3), docosapentaenoic acid (22:5 n-3) and mixtures thereof, especially metabolites including stearidonic acid.
L'invention concerne un procédé permettant de traiter le cancer chez les mammifères, qui consiste à administrer au mammifère ayant besoin d'un tel traitement une dose inhibant le cancer de métabolite(s) de l'acide .alpha.-linolénique, tels que l'acide stéaridonique (18:4 n-3), l'acide arachidonique (20:4 n-3), l'acide docosapenténoïque (22:5 n-3) et des mélanges de ces acides, notamment les métabolites comprenant de l'acide stéaridonique.
Hummert Susan
Kabakibi Ayman
Lindemann Julie
Obukowicz Mark
Olson Lisa M.
Mcfadden Fincham
Monsanto Technology Llc
LandOfFree
Use of .alpha.-linolenic acid metabolites for treatment or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of .alpha.-linolenic acid metabolites for treatment or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of .alpha.-linolenic acid metabolites for treatment or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1687756